lomerizine has been researched along with benidipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, DK; Kim, DK; Kim, JH; Kim, JW; Kwon, OB; Lee, DS; Lee, H; Lee, J; Lee, S; Min, SH; Yu, JH | 1 |
| Ding, L; Jiang, P; Li, L; Liu, S; Lu, W; Xu, X; Yang, C; Zhou, P | 1 |
2 other study(ies) available for lomerizine and benidipine
| Article | Year |
|---|---|
Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells.
Topics: Animals; Antihypertensive Agents; Apoptosis; Calcium Channel Blockers; Calcium Channels; Carcinoma, Ovarian Epithelial; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dihydropyridines; Drug Repositioning; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Nitrobenzenes; Ovarian Neoplasms; Paclitaxel; Piperazines; Signal Transduction; Tumor Microenvironment | 2020 |
T-type calcium channels blockers inhibit HSV-2 infection at the late stage of genome replication.
Topics: Animals; Antiviral Agents; Calcium Channel Blockers; Calcium Channels, T-Type; Calcium Signaling; Chlorocebus aethiops; Dihydropyridines; Gene Expression Regulation, Viral; HeLa Cells; Herpes Genitalis; Herpesvirus 2, Human; Host-Pathogen Interactions; Humans; Piperazines; Vero Cells; Virus Replication | 2021 |